ANTHROLOG
Live / Applied — First extension granted (statement of use) (as of 17 Nov 2025)
What this means for you
Not registered yet, but its 23 Jul 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98662116
- Mark type
- Stylized text
- Filed
- 23 Jul 2024
- Published for opposition
- 08 Apr 2025
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 001 — Chemicals: Biological and chemical agents for scientific and research use, namely, biological and chemical preparations for use in the development and manufacture of pharmaceuticals
- Class 009 — Scientific and electric apparatus: Downloadable software for generating chemical compounds with targeted biological and chemical activity and drug efficacy for use in molecular research, research and development of pharmaceutical products and chemical compounds, design of chemical structures in the pharmaceuticals and healthcare fields; downloadable software featuring artificial intelligence for generating chemical compounds with targeted biological and chemical activity and drug efficacy for use in molecular research, research and development of pharmaceutical products and chemical compounds, design of chemical structures, and analysis of biological or chemical activity; downloadable software enabling the use of artificial intelligence for discovering and designing biomolecules, chemical structures, and pharmaceuticals for use in the biotechnology field
- Class 042 — Scientific and technological services: Providing online non-downloadable software for generating chemical compounds with targeted biological and chemical activity and drug efficacy for use in molecular research, research and development of pharmaceutical products and chemical compounds, design of chemical structures in the pharmaceuticals and healthcare fields; providing on-line non-downloadable software featuring artificial intelligence for generating chemical compounds with targeted biological and chemical activity and drug efficacy for use in molecular research, research and development of pharmaceutical products and chemical compounds, design of chemical structures, and analysis of biological or chemical activity; providing on-line non-downloadable software for operating the use of artificial intelligence for discovering and designing biomolecules, chemical structures, and pharmaceuticals for use in the biotechnology field
Owner
- Montai Therapeutics, Inc., Cambridge, MA, US
- Montai Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 17 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Nov 2025 — SOU EXTENSION 1 GRANTED
- 17 Nov 2025 — SOU EXTENSION 1 FILED
- 17 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Apr 2025 — PUBLISHED FOR OPPOSITION
- 02 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 13 Mar 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 13 Mar 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 06 Feb 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 06 Feb 2025 — NON-FINAL ACTION E-MAILED
- 06 Feb 2025 — NON-FINAL ACTION WRITTEN